Nexavar 200 mg tablet is unsafe to use during pregnancy.There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.

SALT INFORMATION for NEXAVAR

Uses

Nexavar 200 mg tablet is used in the treatment of kidney cancer, thyroid cancer and liver cancer.

How it works

Nexavar 200 mg tablet belongs to the class of drugs called multikinase inhibitors. It slows down the rate of growth of cancer cells by blocking the action of an abnormal protein that signals cancer cells to multiply. It cuts down the blood supply to the cancer cells and stops their growth and proliferation.

Expert advice for NEXAVAR

Inform the doctor if you are suffering from high blood pressure, bleeding problems, chest pain, heart problems (prolongation of QT interval), kidney problems other than kidney cancer, or liver disease; if you are going to have a surgery or have been recently operated upon.

Seek immediate medical attention if you experience chest pain, severe dizziness, fainting, sweating or shortness of breath, blood in your urine or stools, abnormal vaginal bleeding, severe stomach pain, coughing up blood, or any bleeding that will not stop while receiving treatment with Sorafenib.

Tell your doctor if you are or planning to become pregnant or are breastfeeding, sorafenib may decrease fertility in men and women.

You may need frequent monitoring of fluid balance and electrolytes if you are at risk of renal dysfunction; monitoring of blood calcium levels and thyroid hormones if you are suffering from thyroid cancer.

Frequently asked questions for NEXAVAR

Sorafenib

Q.Is sorafenib effective in chemotherapy?Sorafenib is effective in chemotherapy of liver, kidney and thyroid cancer

Q.Is sorafenib cytotoxic?Sorafenib is a cytotoxic agent

Q.How is sorafenib taken/administered?Sorafenib is administered orally in the form of two tablets of 200 mg twice a day (total daily dose of 800 mg) on empty stomach at least 1 hour before or 2 hours after eating

Q.What does sorafenib target?Sorafenib targets the cancer cells to stop their growth and proliferation.